Spending Gaps In Global Health R&D Threaten Innovation Against Infectious Diseases, Study Shows
Health Policy Watch: New Analysis Reveals Significant Gaps In Funding For Health Innovation
“Many of the products critically needed to fight some of the world’s most prevalent infectious diseases are not likely to be developed. This is the outcome of a new analysis, which reveals significant gaps in funding for health innovation…” (Ueberschlag, 9/4).
New York Times: Vaccines Against HIV, Malaria and Tuberculosis Unlikely, Study Says
“…To make real progress against this variety of infectious diseases by 2030, the study concluded, the world must increase research spending to nearly $9 billion a year; it now spends only about $3 billion. But the world is moving in the opposite direction…” (McNeil, 9/7).